Novartis AG  logo
NVSNovartis AG
Trade NVS now
Novartis AG  primary media

About Novartis AG

Novartis (SWX:NOVN), (NYSE:NVS) is a multinational pharmaceutical company that focuses on the research, development, manufacturing, and marketing of a wide range of healthcare solutions. Its operations span innovative patented medicines, generic and biosimilar pharmaceuticals, and eye care devices. Projects include vaccine development and novel therapies for diseases. The firm's objectives aim to address the evolving needs of patients and societies worldwide by discovering new ways to improve and extend people’s lives and by pioneering innovative approaches to help people around the world access high-quality medicine.

What is NVS known for?

Snapshot

Public US
Ownership
1996
Year founded
77130
Employees
Basel, Switzerland
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Switzerland

Products and/or services of Novartis AG

  • Innovative medicines and generics under Sandoz offering broad spectrum healthcare solutions combatting a range of conditions.
  • Cell and gene therapy treatments applying pioneering science to revolutionize patient care and create transformative therapies.
  • Drug discovery technologies with NIBR, advancing the depths of biomedical research.
  • Oncology segment, providing comprehensive cancer care with an array of treatments and therapies.
  • Eye care solutions through Alcon, helping millions improve and preserve their vision.
  • Clinical research solutions with data intelligence capabilities, enhancing the detection, diagnosis, and treatment of diseases.

Novartis AG executive team

  • Dr. Vasant Narasimhan M.D.Chief Executive Officer
  • Mr. Harry KirschChief Financial Officer
  • Mr. Victor BultoPresident of US
  • Dr. Patrick Horber M.D.President of International
  • Dr. Steffen Lang Ph.D.President of Operations
  • Paul PenepentHead of Group Financial Reporting and Accounting
  • Ms. Sloan SimpsonGlobal Head of Investor Relations
  • Ms. Karen L. HaleChief Legal & Compliance Officer
  • Dr. Robert Kowalski Pharm.D.Chief People & Organization Officer
  • Dr. Linda W. Armstrong M.D.Global Head of Respiratory Development

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.